Clinical Trials Directory

Trials / Conditions / Stage IIC Fallopian Tube Cancer AJCC v6 and v7

Stage IIC Fallopian Tube Cancer AJCC v6 and v7

10 registered clinical trials studyying Stage IIC Fallopian Tube Cancer AJCC v6 and v7.

StatusTrialSponsorPhase
WithdrawnWeb-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With
NCT03902379
Rutgers, The State University of New JerseyN/A
UnknownDiet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previo
NCT00719303
Gynecologic Oncology GroupPhase 3
CompletedPropranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian
NCT01504126
M.D. Anderson Cancer CenterEARLY_Phase 1
UnknownChemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovar
NCT01366183
Gynecologic Oncology Group—
UnknownQuality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer,
NCT01372787
Gynecologic Oncology Group—
Active Not RecruitingCarboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy i
NCT01081262
National Cancer Institute (NCI)Phase 3
Active Not RecruitingPaclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage
NCT01167712
National Cancer Institute (NCI)Phase 3
CompletedCarboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovar
NCT00989651
National Cancer Institute (NCI)Phase 1
UnknownPaclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Ut
NCT00954174
GOG FoundationPhase 3
CompletedBevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epi
NCT00951496
National Cancer Institute (NCI)Phase 3